Page last updated: 2024-09-04

fusidic acid and troglitazone

fusidic acid has been researched along with troglitazone in 4 studies

Compound Research Comparison

Studies
(fusidic acid)
Trials
(fusidic acid)
Recent Studies (post-2010)
(fusidic acid)
Studies
(troglitazone)
Trials
(troglitazone)
Recent Studies (post-2010) (troglitazone)
1,7421173441,857146287

Protein Interaction Comparison

ProteinTaxonomyfusidic acid (IC50)troglitazone (IC50)
Bile salt export pumpRattus norvegicus (Norway rat)3.9
Bile salt export pumpHomo sapiens (human)5.05
Carbonic anhydrase 2Homo sapiens (human)0.97
Adenosine receptor A3Homo sapiens (human)5.208
Cytochrome P450 2C9 Homo sapiens (human)4
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)5.208
Thromboxane-A synthase Homo sapiens (human)2.966
Amine oxidase [flavin-containing] BHomo sapiens (human)2.07
Mitogen-activated protein kinase 1Homo sapiens (human)1.238
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)1.03
5-hydroxytryptamine receptor 2BHomo sapiens (human)1.312
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)5.208
ATP-binding cassette sub-family C member 8Homo sapiens (human)1.285
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)1.285
Indoleamine 2,3-dioxygenase 2Mus musculus (house mouse)4.5

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Other Studies

4 other study(ies) available for fusidic acid and troglitazone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013